Arizona could spend $30 million to study psychedelic mushrooms

Arizona would spend $30 million to research psychedelic mushrooms as a treatment for a variety of disorders under a bipartisan proposal at the state capitol.

House Bill 2486 is groundbreaking not only because it would enable such research, but also because it would lead to peer-reviewed research into the effects of natural psilocybin mushrooms, rather than a synthetic version of the drug commonly used in such studies is used.

Psilocybin is the psychoactive compound found in many types of mushrooms used by people recreationally and, increasingly, medicinally. It is a Schedule I substance under the Controlled Substances Act, which means that the Drug Enforcement Administration does not currently recognize any medical use for it.

The bill is part of a wave of similar proposals and actions across the country as states open the door to treating people with psilocybin and exploring its potential to help with conditions such as post-traumatic stress disorder, depression, anxiety, obsessive-compulsive disorder and addiction.


Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button